USE OF ALENDRONATE FOR THE MANUFACTURE OF MEDICAMENT FOR PREVENTION OF PERIPROSTHETIC BONE LOSS WITH PATIENTS HAVING AND ORTHOPEDIC IMPLANT DEVICE

摘要

Disclosed is a therapy for treating and for preventing periprosthetic bone loss by the administration of a bisphosphonate bone resorption inhibitor, e.g., alendronate, in patients who have an orthopedic implant device.